THEO-DUR — THEOPHYLLINE EXTENDED-RELEASE TA

✓ Government record, cited

— · COMPONENT

PRODUCT OVERVIEW

THEO-DUR: THEOPHYLLINE EXTENDED-RELEASE TA.

THEOPHYLLINE EXTENDED-RELEASE TA. Key specifications include special_features: LONG ACTION METHOD:EXTENDED RELEASE;, features_provided: INDIVIDUALLY SEALED, primary_container_type: PACKAGE, supplementary_features: MEDSEP ITEM FOR DOD,SCHERING CORP. PHARMACEUTICAL DIV; DIV OF SCHERING-PLOUGH CORP., therapeutic_equivalent: THEO-DUR BY KEY PHARM, primary_container_content_quantity: 100.000 TABLETS.

This part is cataloged in the U.S. Government catalog under NSN 6505-01-037-5607, indicating validated use in U.S. government and defense logistics supply chains.

Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels. Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS

THEO-DUR

NSN: 6505-01-037-5607
NIINs: 010375607, 010375613, 010731552, 010939476, 012912657
FSC: 6505 — Drugs and Biologicals
CAGE: 1F095 — SCHERING-PLOUGH CORPORATION (USA)

SPECIFICATIONS

special_features	LONG ACTION METHOD:EXTENDED RELEASE;
features_provided	INDIVIDUALLY SEALED
primary_container_type	PACKAGE
supplementary_features	MEDSEP ITEM FOR DOD,SCHERING CORP. PHARMACEUTICAL DIV; DIV OF SCHERING-PLOUGH CORP.
therapeutic_equivalent	THEO-DUR BY KEY PHARM
primary_container_content_quantity	100.000 TABLETS
active_medicament_medicinal_strength	200.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
part_name_assigned_by_controlling_agency	THEOPHYLLINE EXTENDED-RELEASE TABLETS 200MG I.S. 100S PG
NSN	6505-01-037-5607

COMPONENT DIAGRAM

KEY FEATURES

•

THERAPEUTIC EQUIVALENT: THEO-DUR BY SCHERING

•

PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS

•

PRIMARY CONTAINER TYPE: BOTTLE

•

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT

TECHNICAL CHARACTERISTICS

THERAPEUTIC EQUIVALENT	THEO-DUR BY SCHERING
PRIMARY CONTAINER CONTENT QUANTITY	100.000 TABLETS
PRIMARY CONTAINER TYPE	BOTTLE
PART NAME ASSIGNED BY CONTROLLING AGENCY	THEOPHYLLINE EXTENDED-RELEASE TABLETS 300MG 100S BT
ACTIVE MEDICAMENT MEDICINAL STRENGTH	300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT

SUBSTITUTES & CROSS-REFERENCES 4

NDC00085-0584-01Reference document

Same NSN cross-reference

Reference document — Design control — primary reference

NDC00258-3581-01Reference document

Same NSN cross-reference

Reference document — Secondary reference

NDC00603-5946-21Reference document

Same NSN cross-reference

Reference document — Secondary reference

THEO-DUR TABLETSReference document

Same NSN cross-reference

Reference document — Secondary reference

LIFECYCLE

NSN statusCancelled· U.S. Government catalog

HAZMAT per U.S. Government catalogShelf-life managedNo demilitarization required

Ready to buy THEO-DUR?

Compare prices from verified sellers on eBay

Buy on eBay →

As an eBay Partner, PartsTable may earn a commission. Your price is not affected.

FREQUENTLY ASKED QUESTIONS

What is THEO-DUR?

THEO-DUR is a THEOPHYLLINE EXTENDED-RELEASE TA.

What parts can replace THEO-DUR?

There are 4 known substitutes for THEO-DUR: NDC00085-0584-01, NDC00258-3581-01, NDC00603-5946-21 and 1 more. Substitute compatibility should be verified for your specific system.

What is the NSN for THEO-DUR?

THEO-DUR is cataloged in the U.S. Government catalog under NSN 6505-01-037-5607. This indicates validated use in U.S. government and defense supply chains.

Community Feedback

THEO-DUR — THEOPHYLLINE EXTENDED-RELEASE TA

Request a Quote — THEO-DUR